Biomea Fusion, Inc. (BMEA) vs Cyteir Therapeutics, Inc. (CYTT)

Biomea Fusion, Inc. and Cyteir Therapeutics, Inc. are both Biotechnology companies. Biomea Fusion, Inc. and Cyteir Therapeutics, Inc. are of similar size ($108.7M and $108.0M). Across the 8 metrics below, Cyteir Therapeutics, Inc. leads on 5 and Biomea Fusion, Inc. on 3.

Valuation

Metric BMEA CYTT Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B 7.87 0.87 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m 0.55 0.74
EV/Sales n/m n/m 10.73
Earnings yield (21.97%) (31.23%) (28.84%)
Free cash flow yield (49.11%) (23.50%) (23.03%)

Profitability

Metric BMEA CYTT Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (164.14%) (23.80%) (57.72%)
Return on assets (59.14%) (22.70%) (49.22%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric BMEA CYTT Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 69.19% 39.35% —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric BMEA CYTT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.48 21.89 4.73
Net debt to EBITDA 0.68 3.10 0.96

Dividend

Metric BMEA CYTT Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric BMEA CYTT Biotechnology median
Market cap 108.00m 108.72m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack